|
NewswireToday - /newswire/ -
Billerica, MA, United States, 2020/11/20 - Today, Bruker announced the launch of the novel RAPIDplus (mod 4) Fourier Transform Infrared (FTIR) based stand-off detector for Chemical Warfare Agents (CWA) and Toxic Industrial Chemicals (TIC) - Bruker.com. NASDAQ: BRKR
|
|
RAPIDplus (mod 4) allows automated, 24/7 monitoring of chemical hazards at distances up to 5 km. It is specifically designed for maritime, coastal, and shipboard environments which makes this instrument unique.
RAPIDplus (mod 4) is based on the field-proven FTIR technology used in the widely deployed RAPIDplus (mod 3). The instrument has been designed with advanced materials selected to withstand harsh maritime environments, with enhanced sealing and a clear focus on maintainability. Our aim was to achieve customer driven needs while maintaining the superior analytical performance of our technology.
RAPIDplus (mod 4) is the first stand-off detector especially designed for maritime environments. The system has been extensively tested against the pertinent military and environmental standards associated with a corrosive environment and has succesfully demonstrated its superior capabilities in this challenging application.
The RAPIDplus (mod 4) is the first chemical stand-off detector designed for maritime applications including the navy, coast guard, port security, and more. We are convinced that the combination of proven Bruker stand-off technology tailored for this application will provide the same high level of reliability, performance and protection that is expected by all of our customers across the globe.” said Dr.-Ing. Armin Gembus, Vice President Business Area Gas Raman and Trace Detection.
About Bruker Corporation
How Bruker has been driven by the idea to always provide the best technological solution for each analytical task
Bruker (bruker.com) is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker’s high-performance scientific instruments and high-value analytical and diagnostic solutions enable scientists to explore life and materials at molecular, cellular and microscopic levels. In close cooperation with our customers, Bruker is enabling innovation, improved productivity and customer success in life science molecular research, in applied and pharma applications, in microscopy and nanoanalysis, and in industrial applications, as well as in cell biology, preclinical imaging, clinical phenomics and proteomics research and clinical microbiology.
Today, worldwide more than 6,000 employees are working on this permanent challenge at over 90 locations on all continents. Bruker continues to build upon its extensive range of products and solutions, its broad base of installed systems and a strong reputation among its customers. Being one of the world's leading analytical instrumentation companies, Bruker is strongly committed to further fully meet its customers’ needs as well as to continue to develop state-of-the-art technologies and innovative solutions for today's analytical questions.
|